PLUMEAZ Trademark
Trademark Overview
On Wednesday, September 17, 2025, a trademark application was filed for PLUMEAZ with the United States Patent and Trademark Office. The USPTO has given the PLUMEAZ trademark a serial number of 99398957. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 12, 2026. This trademark is owned by MannKind Corporation. The PLUMEAZ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases; Pharmaceutical preparations for inhalation for the treatment of lung infections, including, mycobacterial infections; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, cancer, endocrine diseases and disorders, metabolic diseases and disorders, and neoplastic diseases and disorders
Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases; Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of insulin, inhaler systems comprising inhalers and cartridges for administration of pharmaceuticals, and inhalers, and cartridges for use with inhalers, all provided empty; medical devices in the nature of inhalers used to measure patient inhalation effort and to train patients in personal inhaler use, medical devices in the nature of inhalers with features for measuring respiratory effort and facilitating the training of patients in use of inhalers, medical devices in the nature of inhalers with features for the measurement of respiratory patterns of patien...
General Information
| Serial Number | 99398957 |
| Word Mark | PLUMEAZ |
| Filing Date | Wednesday, September 17, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, February 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases; Pharmaceutical preparations for inhalation for the treatment of lung infections, including, mycobacterial infections; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, cancer, endocrine diseases and disorders, metabolic diseases and disorders, and neoplastic diseases and disorders |
| Goods and Services | Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases; Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of insulin, inhaler systems comprising inhalers and cartridges for administration of pharmaceuticals, and inhalers, and cartridges for use with inhalers, all provided empty; medical devices in the nature of inhalers used to measure patient inhalation effort and to train patients in personal inhaler use, medical devices in the nature of inhalers with features for measuring respiratory effort and facilitating the training of patients in use of inhalers, medical devices in the nature of inhalers with features for the measurement of respiratory patterns of patients, medical devices included as a component of inhaler systems for medical use, namely, patient monitors for monitoring and measuring respiration, apparatus for diagnosing or treating respiratory conditions, medical devices included as a component of inhaler systems for medical use, namely, devices used to indicate dosing of medication, medical devices included as a component of inhaler systems for medical use, namely, devices used to transmit and receive data regarding inhalation, respiration, or dosage. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 17, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 17, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MannKind Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Danbury, CT 06810 |
Trademark Events
| Event Date | Event Description |
| Wednesday, September 17, 2025 | NEW APPLICATION ENTERED |
| Wednesday, September 17, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, February 9, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 10, 2026 | ASSIGNED TO EXAMINER |
| Thursday, February 12, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, February 12, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, February 12, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
